Analysts Set $14.00 Price Target for 111 Inc – (NASDAQ:YI)
111 Inc – (NASDAQ:YI) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 12 month consensus target price of $14.00 for the company, according to Zacks. Zacks has also assigned 111 an industry rank of 87 out of 256 based on the ratings given to its competitors.
Shares of 111 stock traded down $0.10 during midday trading on Thursday, hitting $4.65. 3,100 shares of the company were exchanged, compared to its average volume of 24,335. The company has a market capitalization of $395.49 million and a price-to-earnings ratio of -4.19. 111 has a 52 week low of $4.60 and a 52 week high of $16.83. The firm has a 50 day simple moving average of $6.28.
An institutional investor recently raised its position in 111 stock. Chiron Investment Management LLC boosted its stake in shares of 111 Inc – (NASDAQ:YI) by 4.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,407,509 shares of the company’s stock after buying an additional 61,626 shares during the quarter. 111 accounts for about 1.1% of Chiron Investment Management LLC’s holdings, making the stock its 28th biggest holding. Chiron Investment Management LLC owned approximately 1.73% of 111 worth $8,473,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 3.93% of the company’s stock.
111 Company Profile
111, Inc, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers.
Recommended Story: What does it mean to hold a stock in street name?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.